This article illustrates the challenges for parties to life sciences transactions in Switzerland, and the key points which should be taken into account in view of the complex and evolving legal and regulatory environment. In particular, it examines due diligence in the life sciences sector, deal structuring and transaction agreements.

This article is part of the global guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-guide.